| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |